Old Web
English
Sign In
Acemap
>
Paper
>
Late Breaking Abstract - Immunomodulatory and clinical effects of RIPK1 inhibitor SAR443122 in patients with severe COVID-19
Late Breaking Abstract - Immunomodulatory and clinical effects of RIPK1 inhibitor SAR443122 in patients with severe COVID-19
2021
Pierre-François Clot
Christine Farenc
Benjamin T. Suratt
Tillmann Krahnke
Agnes Tardat
Peter Florian
Robert Pomponio
Naimish Patel
Maria Wiekowski
Yong Lin
Benjamin Terrier
Heribert Staudinger
Keywords:
Coronavirus disease 2019
RIPK1
Internal medicine
Medicine
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]